Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction

BACKGROUND: Early withdrawal of recommended antiplatelet treatment with clopidogrel adversely affects prognosis following percutaneous coronary interventions. Optimal antiplatelet treatment is essential following ST‐segment elevation myocardial infarction (STEMI) given the increased risk of thrombot...

Descripción completa

Detalles Bibliográficos
Autores principales: Koskinas, Konstantinos C., Zanchin, Thomas, Klingenberg, Roland, Gencer, Baris, Temperli, Fabrice, Baumbach, Andreas, Roffi, Marco, Moschovitis, Aris, Muller, Oliver, Tüller, David, Stortecky, Stefan, Mach, Francois, Lüscher, Thomas F., Matter, Christian M., Pilgrim, Thomas, Heg, Dik, Windecker, Stephan, Räber, Lorenz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015438/
https://www.ncbi.nlm.nih.gov/pubmed/29654204
http://dx.doi.org/10.1161/JAHA.117.008085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015438/
https://www.ncbi.nlm.nih.gov/pubmed/29654204
http://dx.doi.org/10.1161/JAHA.117.008085

Ejemplares similares